Crescent Biopharma (CBIO) Enterprise Value (2014 - 2026)
Crescent Biopharma's Enterprise Value was $328.01 million in Q2 2026, compared with -$90.39 million a year earlier and up 3.4% from the prior quarter.
Powered by 
Analysis
Crescent Biopharma (CBIO) Enterprise Value (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Crescent Biopharma's Enterprise Value was -$207.68 million through Jun 30, 2026; for FY2025, it came in at -$89.69 million.
- In earlier years, Enterprise Value was $1.58 billion in FY2024 (-89.6%), $15.16 billion in FY2023 (-7.8%), $16.43 billion in FY2022 (+135.8%) and $6.97 billion in FY2021 (-61.9%).
- The Q2 2026 figure marks the highest quarterly Enterprise Value since Q1 2025.
- The best year-over-year quarter for Enterprise Value over five years was Q2 2023 (growth of 260.8%); the worst was Q3 2025 (a decline of 97.1%).
- Per Business Quant data, CBIO's Enterprise Value in the three quarters before Q2 2026 was $317.3 million (Q1 2026), -$89.69 million (Q4 2025) and $31.88 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Crescent Biopharma | 403.30 Mn | -304.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 328.01 Mn |
| Mar 31, 2026 | 317.30 Mn |
| Dec 31, 2025 | -89.69 Mn |
| Sep 30, 2025 | 31.88 Mn |
| Jun 30, 2025 | -90.39 Mn |
| Mar 31, 2025 | 1.33 Bn |
| Dec 31, 2024 | 1.58 Bn |
| Sep 30, 2024 | 1.08 Bn |
| Jun 30, 2024 | 1.78 Bn |
| Mar 31, 2024 | 19.30 Bn |
| Dec 31, 2023 | 15.16 Bn |
| Sep 30, 2023 | 9.61 Bn |
| Jun 30, 2023 | 11.13 Bn |
| Mar 31, 2023 | 8.03 Bn |
| Dec 31, 2022 | 16.43 Bn |
| Sep 30, 2022 | 2.83 Bn |
| Jun 30, 2022 | 3.09 Bn |
| Mar 31, 2022 | 5.82 Bn |
| Dec 31, 2021 | 6.97 Bn |
| Sep 30, 2021 | 11.23 Bn |
API Access
Crescent Biopharma Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();